Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
NCT05548205

Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge

Led by NYU Langone Health · Updated on 2025-10-02

150

Participants Needed

1

Research Sites

123 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The proposed study will be a randomized, prospective, non-blinded study of 120 participants with type 1 or type 2 diabetes that are new-to-insulin on hospital discharge. On hospital discharge, participants will be assigned to either the intervention of wearing a continuous glucose monitor (CGM) for 2 weeks or blood glucose monitoring (BGM) for 2 weeks. They will have a 2-week follow up visit, during which insulin doses will be adjusted as needed, and a 3-month follow-up visit, at which point HbA1c will be measured.

CONDITIONS

Official Title

Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18-100 years
  • Known history of type 1 or type 2 diabetes
  • Admitted to NYU Langone Hospital - Long Island between December 16, 2024 and December 31, 2026
  • New initiation of insulin therapy at the time of hospital discharge, including basal insulin, basal-bolus insulin, or mixed insulin regimen
Not Eligible

You will not qualify if you...

  • Prior use of insulin therapy before hospital admission
  • Current use of systemic corticosteroids
  • Active pregnancy, determined by patient self-reporting; females who become pregnant during the study will be withdrawn

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NYU Langone Hospital - Long Island

Mineola, New York, United States, 11501

Actively Recruiting

Loading map...

Research Team

M

Michael Goldstein

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here